PubMed Health⌕ Search

PubMed · 9256006

[Thrombosis and apoptosis].

Abstract

Apoptosis is a controlled form of cell death that allows the removal of cells during physiological or pathological processes. Recent studies suggested a potential link of apoptosis with processes leading to thrombophilia. In this review, we describe the mechanisms by which apoptotic cells would cause activation of blood coagulation and instability of atherosclerotic plaque leading to increased thrombus formation. A well-recognized acquired thrombophilia is the anti-phospholipid syndrome. Alterations of the phospholipid phase of cell membranes in the course of membrane blebbing, a characteristic morphological change occurring during the late apoptotic process, have been shown to be associated with the production of anti-phospholipid antibodies. These surface blebs on apoptotic cells have been shown to be the sites of enhanced procoagulant activity. Reversely, several anti-phospholipid antibodies may also induce apoptosis resulting in the formation of immunogenic and highly procoagulant surface blebs. Apoptosis was also found to be associated with increased cell surface tissue factor procoagulant activity, the so called tissue factor de-encryption. Atherosclerotic plaque rupture is associated with increased thrombus formation. Apoptotic inflammatory cells such as macrophages and T cells are abundant in atherosclerotic plaque and may be related to plaque instability. During the process of endothelial cell apoptosis, a loss of the anticoagulant property of endothelial cell surface concomitantly with an increase in their adhesiveness for leukocytes might probably occur. These changes may be important for the rapid progression of the atherosclerotic process.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

H Takeya, Y Tanaka, K Suzuki. 1997. [Thrombosis and apoptosis].. https://pubmed.ncbi.nlm.nih.gov/9256006/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Binding of antiphospholipid antibodies to discontinuous epitopes on domain I of human beta(2)-glycoprotein I: mutation studies including residues R39 to R43.

OBJECTIVE: Pathogenic antiphospholipid antibodies (aPL) bind the self antigen N-terminal domain (domain I) of beta(2)-glycoprotein I (beta(2)GPI), with residues G40-R43 being important. However, peptides homologous to other regions of domain I have also been shown to bind aPL. Furthermore, there are no published reports of the effects of altering R39, which has greater surface exposure than the G40-R43 residues. METHODS: We used a novel, efficient method of production and purification of human domain I by Escherichia coli to create multiple mutants of domain I. These domain I mutants were then screened for binding to a range of polyclonal IgG purified from patients with antiphospholipid syndrome, using both solid-phase and fluid-phase assays. RESULTS: E coli-expressed purified domain I selectively bound IgG derived from patients with antiphospholipid syndrome. In region R39-R43, the R39S mutation had the greatest effect in terms of reducing binding to a panel of aPL in the fluid phase (mean +/- SD inhibition 14 +/- 18.5% versus 44.1 +/- 31.7% for G40E and 62.9 +/- 25.7% for wild-type domain I). Conversely, altering both D8 and D9 to S8 and G9, respectively, had the effect of enhancing binding to aPL in the fluid phase. Adding the remainder of the domain I-II interlinker resulted in enhanced binding over wild-type in the solid phase but not the fluid phase. CONCLUSION: The binding of aPL to beta(2)GPI domain I is complex and likely to involve discontinuous epitopes that include R39 in addition to G40-R43, the domain I-II interlinker, and possibly D8 and D9. Domain I variants with enhanced binding to aPL compared with wild-type domain I may aid in the development of novel therapies.

Antibodies, Antiphospholipid↗

A case of Churg-Strauss syndrome associated with antiphospholipid antibodies.

Churg-Strauss syndrome (CSS) is a systemic vasculitis affecting both small- and medium-sized blood vessels, almost invariably affecting the lung, and frequently associated with cutaneous involvement. Microvascular vaso-occlusion leading to digital gangrene is not a feature of CSS. We report an unusual case of a patient with CSS with antiphospholipid antibodies who developed severe digital gangrene in addition to cutaneous vasculitis. The presence of antiphospholipid antibodies is not a feature usually seen in association with CSS. While the full clinical spectrum of CSS is still being defined, the identification of additional features associated with this syndrome might help to better understand the pathogenesis of the disease and to have an impact on both management and prognosis.

Antibodies, Antiphospholipid↗